


Oncology
2023-04-21

Compared with NCG mice, NCG-hIL2 mice can reconstitute more Tregs after human PBMCs transplantation and more NK cells after human HSC transplantation. NCG-hIL2 is a potential mouse model for the preclinical study of anti-tumor therapeutics that utilize Tregs and/or NK cells.
More infomation about blogs

Let us know which event you're attending and we'd be happy to connect with you.
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
